The Gago Conferences

The Gago Conferences on European Science Policy provide an international forum to strengthen the debate on emerging issues of research and innovation policy in Europe, as well as to promote the necessary involvement of major stakeholders in policy making and the diffusion of knowledge in science education and culture. The Conferences seek also to strengthen international scientific and technological cooperation networking in Europe towards a positive impact on a global scale.

Science and technology (S&T) are key global resources for our collective future, our wealth, job creation and shared prosperity, both at home and abroad. The impact of S&T and innovation are the result of a cumulative, long-term, collective and uncertainty process, involving an extensive division of labour, which requires massifying the training of human resources and qualifying the labour force in many economic sectors. Increasing interest in these processes has been driving innovative research and practice across a wide range of businesses and academic disciplines - from management, marketing, engineering and economics to public policy, sociology, history and law.


"Science is a battle ground, it's not neutral.
And if you know it's not neutral, it becomes interesting.
It can become part of the modern youth culture.
You must choose between generosity and greed,
between peace and war,
and choose between disclosing or hiding the truth"...


José Mariano Gago (2001)

The primary objective of these conferences is to bring together leading representatives from academic, business, social, culture and government sectors worldwide to present and discuss current and future issues of critical importance for European science and technology, including their impact to foster social and economic development and shared prosperity both at home and abroad. Multidisciplinary perspectives are encouraged to provide state-of-the-art and useful knowledge to decision makers in the private, public and social sectors - including informed and effective education, culture, business, government policies and strategies for Europe.


Organizing Committee:

  • Julio E. Celis, Danish Cancer Society Research Centre, DK
  • Manuel Heitor, Minister for Science, Technology and Higher Education, PT
  • Rosalia Vargas, Ciencia Viva Agency, PT
  • Teresa Riera Madurell, Former member of the European Parliament, SP

International Secretariat:

  • Ciência Viva Agency, Lisbon, Portugal

The 1st Gago Conference on European Science Policy, 2018

"Policy Perspectives for Cancer Research in Europe"

Porto, Portugal, February 14 | 9am - 6pm
i3S, University of Porto at Jose Mariano Gago Auditorium
Rua Alfredo Allen, 208 | 4200-135 Porto


The 1st Gago Conference on European Science Policy will focus on cancer research in Europe. This is because cancer is one of the major health problems affecting our society, a situation that is set to deteriorate globally as the population grows and ages. According to the International Agency for Research on Cancer (IARC), in 2012 there were 1.28 million cancer deaths in the European Union (EU-28), a number that is projected to increase by 30% to 1.67 million in 2030. At the same time, the number of patients newly diagnosed with cancer in the EU is expected to rise to 3.3 million, from 2.6 in 2012.

As a result of more effective treatments and growing number of lines of treatments, cancer is gradually becoming a chronic disease, and the prevalence will rise considerably in countries where life expectancy is already high, as is the case in the EU. Today, cancer places a substantial extra demand on the healthcare systems due to the required surveillance and continuing treatment of both the disease and the observed side effects. According to the European Academy of Cancer Sciences (EACS), "the formidable healthcare problem will be difficult to control unless cancer research improves disease outcome or prevents disease. Prevention, screening, diagnosis, and improved treatment and care are major strategies that may also reduce mortality rates. Furthermore, given the large number of cancer patients and survivors, focusing on their quality-of-life is fundamental".

Even though much hope has emerged from recent advances in our understanding of the molecular mechanisms underlying the disease(s), the pathways through which discoveries translate into therapeutics and diagnostics that benefit patients are complex and challenging to navigate, and as a result, the process is slow, lengthy, and in most cases, inefficient. Translational cancer research has the patient at the centre and requires multidisciplinarity, i.e. collaboration between basic researchers having different expertise, medical oncologists, pathologists, radiation oncologists, surgeons, quality of life researchers, epidemiologists, patients, universities, industry and SMEs, healthcare professionals, regulatory bodies, and funders. Also, it requires scores of patients, sharing of research and clinical data, mindful of the need to protect the privacy of those patients and access to infrastructures and new technologies, all of which must be cross-compatible, responsive to the needs of research and of sufficiently large scale to enable studies of statistical significance ranging from efficacy/effectiveness to outcome research for quality assurance of cancer care and long-term follow-up.

Currently, there are many barriers to translational research that hinder the process and the breadth and scope of these challenges have called for a change in the cultural attitude towards cancer research in Europe, especially in today's era of personalized/precision cancer medicine. A shift from regional/national efforts into continent-wide collaborations and a concerted effort involving all stakeholders is deemed critical to accelerating the pathway from laboratory discoveries to diagnostics and treatments that meet the needs of patients and that the healthcare systems can afford. Such a shift requires robust dialogue between the public, knowledge producers in many domains, and parliamentarians that represent the different political views both nationally and at a European level. Moreover, decision-makers must recognize that sustaining cancer research, in the long-term, will bring significant benefits for European citizens and the economy, as health is wealth!

Presently, there are ongoing efforts to build an ecosystem/infrastructure that combines innovative prevention and treatment strategies in a sustainable state-of-the-art virtual European cancer centre/infrastructure with the critical mass of expertise and resources that is needed to develop capabilities, foster knowledge, and create societal and economical added value across Europe. The aim being improving patients' life and care by innovating at the forefront of the whole cancer continuum.


Organizers of the 1st Gago Conference on EU Science Policy:

  • Julio E. Celis, Danish Cancer Society Research Centre, DK
  • Manuel Heitor, Minister for Science, Technology and Higher Education, PT
  • Manuel Sobrinho Simões, i3S/Ipatimup, Porto Comprehensive Cancer Centre, University of Porto, PT
  • Mario Barbosa, Director, i3S/INEB, University of Porto, PT
  • Teresa Riera Madurell, Former member of the European Parliament, SP


Program

February 13th, 2018 - 8pm: CONFERENCE DINNER

Location: Clube Universitário do Porto

Rua do Campo Alegre, 877, 4150-180 Porto


February 14th, 2018: CONFERENCE PROGRAM

Location: i3S, University of Porto, at Jose Mariano Gago Auditorium

Rua Alfredo Allen, 208, Porto


08:30-09:00 - Registration

09:00-09:30 - Welcome and Opening addresses

Chair: Manuel Heitor (Portuguese Minister for Science, Technology and Higher Education)

  • Manuel Heitor (Portuguese Minister for Science, Technology and Higher Education)
  • Adalberto Campos Fernandes (Portuguese Minister of Health)
  • Fernando Freire de Sousa (President, CCDR Norte; NORTE 2020)
  • Alexandre Quintanilha (Member of Portuguese Parliament)
  • Mário Barbosa (Director, i3S/INEB, University of Porto)

09:30-10:00 - Keynote Speech:

  • Ulrik Ringborg (Cancer Centre Karolinska): "The Cancer Research Continuum"

10:00 - 10:30 - Coffee break

10:30-12:15 - Session 1. Comprehensive Cancer Centres

Chair: Manuel Sobrinho Simões (i3S/Ipatimup, University of Porto)

  • Simon Oberst (Cambridge Cancer Centre): Accreditation of Comprehensive Cancer Centers
  • Anton Berns (European Association for Cancer Research): Designation of Comprehensive Cancer Centers of Excellence

Roundtable:

Moderator: Manuel Sobrinho Simões (i3S/Ipatimup)

  • Jose Laranja Pontes (Instituto Português de Oncologia - IPO-PORTO)
  • Peter Nagy (National Institute of Oncology, Budapest)
  • Christof Von Kalle (German Cancer Research Center - DKFZ)
  • Carlos Caldas (Cambridge Cancer Centre)
  • Bengt Jonsson (Stockholm School of Economics)
  • Elisabete Weiderpass (Cancer Registry of Norway & Karolinska Institutet, Sweden)
  • Gunnar Saeter (Comprehensive Cancer Centre, Oslo University Hospital)
  • Thierry Philip (Organisation of European Cancer Institutes)

12:15-13:15 - Lunch break

13:15-15:15 - Session 2. A Mission-oriented approach to cancer research in Europe: Building communities to develop capabilities, foster knowledge, and create societal and economical added value across Europe:

Chair: Julio E. Celis (Danish Cancer Society)

Speakers:

  • Alexander Eggermont (Cancer Core Europe)
  • Christopher Wild (Cancer Prevention Europe)

Roundtable:

Moderator: Julio E. Celis (Danish Cancer Society)

  • Michael Bauman (German Cancer Research Center - DKFZ)
  • Frédérick Bordry (European Organization for Nuclear Research - CERN)
  • Karin Sipido (Scientific Panel for Health H2020)
  • Erik Steinfelder (BBMRI-ERIC)
  • Mário Barbosa (i3S/INEB)
  • David Forman (International Agency for Research on Cancer - IARC)
  • Giovanni Apolone (Instituto Nazionale dei Tumori)
  • Kathi Apostolidis (European Cancer Patient Coalition & Greek Cancer Patients Federation)
  • Denis Lacombe (European Organisation for Research and Treatment of Cancer - EORTC)
  • Karim Berkouk (Directorate General for Research & Innovation, European Commission)

15:15-15:30 - Coffee break

15:30-16:30 - Session 3. The social dimension

Moderator: Teresa Riera Madurell (Former member of the European Parliament)

Roundtable:

  • Kathi Apostolidis (European Cancer Patient Coalition & Hellenic Cancer Federation - ELLOK)
  • Maria Graça Carvalho (Directorate General for Research & Innovation)
  • Fabien Calvo (Cancer Core Europe)
  • Ulrik Ringborg (Cancer Centre Karolinska)
  • Françoise Meunier (European Organisation for Research and Treatment of Cancer - EORTC)
  • Bengt Jonsson (Stockholm School of Economics)
  • Dorthe Cruger (Danish Cancer Society Research Centre)

16:30-17:15 - Session 4.The European state of affairs

Chair: Adalberto Campos Fernandes (Portuguese Minister of Health)

Ministerial Roundtable and Discussion

  • Jean-Pierre Bourguignon (European Research Council)
  • Clara Eugénia García (Secretariat of State for Research, Development and Innovation, Spain)
  • Feliksas Jankevicius (National Cancer Institute of Lithuania)
  • Nektarios Tavernarakis (Foundation of Research and Technology, Greece)
  • Marc Van den Bulcke (Cancer Center, Belgium)

  • 17:15-17:30 Keynote Speech: Carlos Moedas, Commissioner for Research, Science and Innovation


    17:30-17:45 - Concluding remarks - "GAGO AWARDS in European Science Policy"

    • Sebastião Feyo de Azevedo (Rector, University of Porto)
    • Fernando Freire de Sousa (President, CCDR Norte; NORTE 2020)
    • Adalberto Campos Fernandes (Portuguese Minister of Health)
    • Manuel Heitor (Portuguese Minister for Science, Technology and Higher Education)


    PREPARE FOR THE DEBATE

    Download here the Paper

    - A mission-oriented approach to cancer in Europe: a joint mission/vision 2030

    By: Julio E. Celis and Dainius Pavalkis


    The registration is closed.

    i3S, University of Porto
    at Jose Mariano Gago Auditorium

    Address:
    Rua Alfredo Allen, 208
    4200-135 Porto


    TRAVEL INFO

    A. Arriving at Porto by train

    Take the train at Campanhã train station or São Bento train station. Metro or bus are available from both stations to the venue. However, the metro is the easiest way to reach i3S, since Pólo Universitário metro station is located in front of i3S entrance.


    • From Campanhã train station:
      Metro: All lines are possible (A, B, C, E and F) | Destination Station: Trindade, then change to line D - yellow (destination Hospital São João) - and leave at station: Pólo Universitário | Average time: 16 minutes | For more information: http://www.metrodoporto.pt/en/

    • From São Bento train station:
      Metro: Line D - yellow | Destination Station: Hospital São João; leave at station: Pólo Universitário (direct line) | Average time: 10 minutes | For more information: http://www.metrodoporto.pt/en/

    B. Arriving at Porto by plane

    Porto´s airport, Francisco Sá Carneiro, is located 11 km from the city center and has direct access via metro.


    • Metro: Line E - purple | Destination station: Estádio do Dragão; leave at station: Trindade. Then, change to line D - yellow (destination Hospital São João) - and leave at station: Pólo Universitário | Average time: 40 minutes | For more information: http://www.metrodoporto.pt/en/

    • Taxi: Approximately 25 minutes.

    C. Arriving at Porto by car

    The i3S Institute - GPS coordinates are: 41º 10' 30.008'' N, 8º 36' 12.488'' W.
    Please note that i3S does not offer parking space.


    ACCOMODATION

    Walking distance to i3S

    • Axis Porto - Business & SPA Hotel ****
      Rua Maria Feliciana, 100 - São Mamede de Infesta | 4465-283 Matosinhos
      Website: http://www.axishoteis.com/pt/Axis-Hoteis
      Telephone: (+351) 229 052 000
      E-mail: reservas@axisporto.com
      Walking distance: 15 minutes

    • Eurostars Oporto Hotel ****
      Rua do Mestre Guilherme Camarinha, 212 | 4200-537 Porto
      Website: http://www.eurostarsoporto.com/
      Telephone: (+351) 225 072 090
      E-mail: reservas@eurostarsoporto.com
      Walking distance: 15 minutes

    • Hotel Ibis São João **
      Rua Dr. Plácido Costa | 4200-450 Porto
      Website: http://www.ibis.com/pt
      Telephone: (+351) 225 513 100
      E-mail: H3227@ACCOR.COM
      Walking distance: 10 minutes

    • Cristal Hotel ****
      Rua Dr. Plácido Costa | 4200-450 Porto
      Website: www.hoteiscristal.pt
      Telephone: (+351) 22 016 1000
      Email: comercialporto@hoteiscristal.pt
      Reservations: bookingporto@hoteiscristal.pt
      Walking distance: 25 minutes

    Accessible by subway from Porto city center

    • NH Collection Porto Batalha ****
      Travessa Antero de Quental 360 Vila Nova de Gaia 4000-087
      Website: https://www.nh-collection.com/pt/hotel/nh-collection-porto-batalha
      Telephone: (+351) 351 210 020 848
      E-mail: nhcollectionportobatalha@nh-hotels.com
      Average time: 20 minutes

    • Trindade Porto Hotel ****
      Rua de Camões, nº 129 / 131 | 4000-144 Porto
      Website: http://www.portotrindadehotel.com/formularios.aspx?id=1
      Telephone: (+351) 222 061 520
      E-mail: geral@portotrindadehotel.com
      Average time: 15 minutes

    • Pão de Açucar Hotel ***
      Rua do Almada, 262 | 4050-032 Porto
      Website: http://www.paodeacucarhotel.pt/
      Telephone: (+351) 222 002 425 / 222 011 589
      E-mail: info@paodeacucarhotel.pt
      Average time: 15 minutes

    • Quality Inn Porto ***
      Praça da Batalha, 127-130 | 4000-102 Porto
      Website: http://www.continentalhotels.eu/site/hotels/view/24.html
      Telephone: (+351) 223 392 300
      E-mail: quality.batalha@grupo-continental.com
      Average time: 20 minutes

    • Palácio do Freixo, Pousada & National Monument *****
      Estrada Nacional 108, 206, 4300-316 Porto
      Website: https://www.pousadapalaciodofreixo.com/pt/
      Telephone: (+351) 22 531 1000
      Email: guest@pousadas.pt
      Average time: 31 minutes

    • Boa Vista Hotel ***
      Esplanada do Castelo, 58, 4150-196 Porto
      Website: http://hotelboavista.com/pt
      Telephone: (+351) 22 532 0020
      e-mail: info@hotelboavista.com
      Average time: 13 minutes